99 related articles for article (PubMed ID: 13679160)
1. Synthesis and vasodilating properties of N-alkylamide derivatives of 4-amino-3-furoxancarboxylic acid and related azo derivatives.
Ovchinnikov IV; Kulikov AS; Makhova NN; Tosco P; Di Stilo A; Fruttero R; Gasco A
Farmaco; 2003 Sep; 58(9):677-81. PubMed ID: 13679160
[TBL] [Abstract][Full Text] [Related]
2. New 1,4-dihydropyridines conjugated to furoxanyl moieties, endowed with both nitric oxide-like and calcium channel antagonist vasodilator activities.
Di Stilo A; Visentin S; Cena C; Gasco AM; Ermondi G; Gasco A
J Med Chem; 1998 Dec; 41(27):5393-401. PubMed ID: 9876109
[TBL] [Abstract][Full Text] [Related]
3. Characterisation of furoxancarbonitriles as a new class of vasodilators.
Gasco AM; Boschi D; Di Stilo A; Medana C; Gasco A; Martorana PA; Schönafinger K
Arzneimittelforschung; 1998 Mar; 48(3):212-8. PubMed ID: 9553676
[TBL] [Abstract][Full Text] [Related]
4. NO-donor phenols: a new class of products endowed with antioxidant and vasodilator properties.
Boschi D; Tron GC; Lazzarato L; Chegaev K; Cena C; Di Stilo A; Giorgis M; Bertinaria M; Fruttero R; Gasco A
J Med Chem; 2006 May; 49(10):2886-97. PubMed ID: 16686532
[TBL] [Abstract][Full Text] [Related]
5. A new class of furoxan derivatives as NO donors: mechanism of action and biological activity.
Ferioli R; Folco GC; Ferretti C; Gasco AM; Medana C; Fruttero R; Civelli M; Gasco A
Br J Pharmacol; 1995 Feb; 114(4):816-20. PubMed ID: 7773542
[TBL] [Abstract][Full Text] [Related]
6. Nicorandil analogues containing NO-donor furoxans and related furazans.
Boschi D; Cena C; Di Stilo A; Fruttero R; Gasco A
Bioorg Med Chem; 2000 Jul; 8(7):1727-32. PubMed ID: 10976520
[TBL] [Abstract][Full Text] [Related]
7. Studies on agents with mixed NO-dependent vasodilating and beta-blocking activities.
Boschi D; Di Stilo A; Cena C; Lolli M; Fruttero R; Gasco A
Pharm Res; 1997 Dec; 14(12):1750-8. PubMed ID: 9453064
[TBL] [Abstract][Full Text] [Related]
8. No-mimetic furoxans: arylsulphonylfuroxans and related compounds.
Ferioli R; Fazzini A; Folco GC; Fruttero R; Calvino R; Gasco A; Bongrani S; Civelli M
Pharmacol Res; 1993; 28(3):203-12. PubMed ID: 8108310
[TBL] [Abstract][Full Text] [Related]
9. Second generation of alpha-tocopherol analogs-nitric oxide donors: Synthesis, physicochemical, and biological characterization.
López GV; Blanco F; Hernández P; Ferreira A; Piro OE; Batthyány C; González M; Rubbo H; Cerecetto H
Bioorg Med Chem; 2007 Sep; 15(18):6262-72. PubMed ID: 17627828
[TBL] [Abstract][Full Text] [Related]
10. Nitric oxide donor beta2-agonists: furoxan derivatives containing the fenoterol moiety and related furazans.
Buonsanti MF; Bertinaria M; Stilo AD; Cena C; Fruttero R; Gasco A
J Med Chem; 2007 Oct; 50(20):5003-11. PubMed ID: 17845020
[TBL] [Abstract][Full Text] [Related]
11. Water soluble furoxan derivatives as NO prodrugs.
Sorba G; Medana C; Fruttero R; Cena C; Di Stilo A; Galli U; Gasco A
J Med Chem; 1997 Feb; 40(4):463-9. PubMed ID: 9046336
[TBL] [Abstract][Full Text] [Related]
12. The furoxan system as a useful tool for balancing "hybrids" with mixed alpha 1-antagonist and NO-like vasodilator activities.
Fruttero R; Boschi D; Di Stilo A; Gasco A
J Med Chem; 1995 Dec; 38(25):4944-9. PubMed ID: 8523408
[TBL] [Abstract][Full Text] [Related]
13. Ursolic acid mediates the vasorelaxant activity of Lepechinia caulescens via NO release in isolated rat thoracic aorta.
Aguirre-Crespo F; Vergara-Galicia J; Villalobos-Molina R; Javier López-Guerrero J; Navarrete-Vázquez G; Estrada-Soto S
Life Sci; 2006 Aug; 79(11):1062-8. PubMed ID: 16630635
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and vasodilative activity of tanshinone IIA derivatives.
Bi YF; Wang ZJ; Guan RF; Ye YT; Chen YY; Zhang YB; Liu HM
Bioorg Med Chem Lett; 2012 Aug; 22(15):5141-3. PubMed ID: 22765898
[TBL] [Abstract][Full Text] [Related]
15. Design and synthesis of novel xyloketal derivatives and their vasorelaxing activities in rat thoracic aorta and angiogenic activities in zebrafish angiogenesis screen.
Xu Z; Li Y; Xiang Q; Pei Z; Liu X; Lu B; Chen L; Wang G; Pang J; Lin Y
J Med Chem; 2010 Jun; 53(12):4642-53. PubMed ID: 20481602
[TBL] [Abstract][Full Text] [Related]
16. Furoxans as nitric oxide donors. 4-Phenyl-3-furoxancarbonitrile: thiol-mediated nitric oxide release and biological evaluation.
Medana C; Ermondi G; Fruttero R; Di Stilo A; Ferretti C; Gasco A
J Med Chem; 1994 Dec; 37(25):4412-6. PubMed ID: 7996554
[TBL] [Abstract][Full Text] [Related]
17. New organic nitrate-containing benzyloxy isonipecotanilide derivatives with vasodilatory and anti-platelet activity.
de Candia M; Marini E; Zaetta G; Cellamare S; Di Stilo A; Altomare CD
Eur J Pharm Sci; 2015 May; 72():69-80. PubMed ID: 25769522
[TBL] [Abstract][Full Text] [Related]
18. New 1,4-dihydropyridines endowed with NO-donor and calcium channel agonist properties.
Visentin S; Rolando B; Di Stilo A; Fruttero R; Novara M; Carbone E; Roussel C; Vanthuyne N; Gasco A
J Med Chem; 2004 May; 47(10):2688-93. PubMed ID: 15115410
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and vasodilatory activity of new N-acylhydrazone derivatives, designed as LASSBio-294 analogues.
Silva AG; Zapata-Sudo G; Kummerle AE; Fraga CA; Barreiro EJ; Sudo RT
Bioorg Med Chem; 2005 May; 13(10):3431-7. PubMed ID: 15848755
[TBL] [Abstract][Full Text] [Related]
20. NO-donor COX-2 inhibitors. New nitrooxy-substituted 1,5-diarylimidazoles endowed with COX-2 inhibitory and vasodilator properties.
Chegaev K; Lazzarato L; Tosco P; Cena C; Marini E; Rolando B; Carrupt PA; Fruttero R; Gasco A
J Med Chem; 2007 Apr; 50(7):1449-57. PubMed ID: 17335184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
